NASDAQ:RCEL
AVITA Medical, Inc. Stock News
$8.10
-0.120 (-1.46%)
At Close: May 24, 2024
Avita (RCEL) Falls 19% on Lowered 2023 Revenue Guidance
09:46am, Wednesday, 22'nd Nov 2023
Avita's (RCEL) stock declines 19% after the company lowered its total revenue guidance for 2023.
AVITA Medical to Present at the Piper Sandler 35th Annual Healthcare Conference
04:15pm, Tuesday, 21'st Nov 2023
VALENCIA, Calif., Nov. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of f
AVITA Medical Updates Full Year 2023 Guidance
04:15pm, Monday, 20'th Nov 2023
VALENCIA, Calif., Nov. 20, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of f
AVITA Medical, Inc. (RCEL) Q3 2023 Earnings Call Transcript
08:39pm, Thursday, 09'th Nov 2023
AVITA Medical, Inc. (NASDAQ:RCEL ) Q3 2023 Results Conference Call November 9, 2023 4:30 PM ET Company Participants Jessica Ekeberg - Director of Investor Relations Jim Corbett - Chief Executive Offic
AVITA Medical Reports Third Quarter Financial Results with 51% Revenue Growth over the Same Period the Prior Year
04:01pm, Thursday, 09'th Nov 2023
VALENCIA, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH) (the “Company”), a regenerative medicine company leading the development and commercialization of f
AVITA Medical Announces Distribution Partnership with PolyMedics Innovations to Expand to Europe
09:00am, Thursday, 09'th Nov 2023
AVITA Medical announced it has entered into a distribution agreement with PolyMedics Innovations, to strategically expand its global presence to Europe.
AVITA Medical to Announce Third Quarter 2023 Financial Results
04:05pm, Thursday, 19'th Oct 2023
VALENCIA, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class device
Why Shares of Avita Medical Are Down Monday
02:37pm, Monday, 02'nd Oct 2023
The FDA is asking for more information regarding Avita's Recell Go device. The Recell Go is a more automated version of an already approved product for Avita.
AVITA Medical to Present at the Cantor Global Healthcare Conference
04:30pm, Thursday, 21'st Sep 2023
VALENCIA, Calif., Sept. 21, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devic
AVITA Medical to Participate in Upcoming Investor Conferences
06:45pm, Wednesday, 06'th Sep 2023
VALENCIA, Calif., Sept. 06, 2023 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a regenerative medicine company leading the development and commercialization of first-in-class devic
AVITA Medical, Inc. (RCEL) Q2 2023 Earnings Call Transcript
10:47pm, Thursday, 10'th Aug 2023
AVITA Medical, Inc. (NASDAQ:RCEL ) Q2 2023 Earnings Conference Call August 10, 2023 4:30 PM ET Company Participants Jessica Ekeberg - Investor Relations James Corbett - Chief Executive Officer David O
AVITA Medical's 'Better Mousetrap' Rapidly Gaining Traction In Skin Repair
08:54am, Thursday, 10'th Aug 2023
AVITA Medical: Innovative device to treat skin injuries gaining sales momentum. Recent FDA approvals of full-thickness skin defects and Vitiligo greatly expand addressable market. Expanded sales force
Strength Seen in Avita Medical Inc. (RCEL): Can Its 20.4% Jump Turn into More Strength?
08:08am, Friday, 14'th Jul 2023
Avita Medical Inc. (RCEL) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the nea
Why Shares of Avita Medical Are Soaring Thursday
02:25pm, Thursday, 08'th Jun 2023
Avita specializes in devices and therapies to restore skin growth. The FDA's nod means that the company's Recell system can expand beyond applications for burn patients.
AVITA (RCEL) Gets FDA Nod for Expanded Use of RECELL System
12:23pm, Thursday, 08'th Jun 2023
AVITA (RCEL) surges on FDA approval for expanded use of its RECELL System to treat full-thickness skin defects.